Coming soon

PrimeTime™ SARS-CoV-2/Flu Test

The COVID-19 pandemic is colliding with flu season. Meet the demand with a multiplex, real-time PCR test that detects influenza A, influenza B, and COVID-19. You've got this. We'll help.

Be the first to know

Loading Form
Trey Martin
President
Integrated DNA Technologies

To everyone who suits up every day to fight the COVID-19 pandemic—whether in research labs, diagnostic centers, or on the front lines—we want to thank you, and do everything we can to support your progress. You’re not fighting alone. We’ll help.

In the news

IDT developing PrimeTime™ SARS-CoV-2/Flu Test for comprehensive patient testing

New test being submitted for Emergency Use Authorization (EUA) is designed to detect SARS-CoV-2, influenza A, and influenza B from a single patient sample

Read more

Explore all SARS-CoV-2 reagents

The PrimeTime™ SARS-CoV-2/Flu Test described on this webpage has not been CE marked or authorized by the U.S. Food and Drug Administration (FDA) or global health agencies. The PrimeTime™ SARS-CoV-2/Flu Test will be submitted by IDT for U.S. FDA Emergency Use Authorization (EUA). If approved: Testing described on this webpage will be designed and intended (i) for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures (ii) for use under the Food and Drug Administration’s Emergency Use Authorization. Testing is limited to laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, to perform high-complexity tests. (iii) The test will only be available for purchase and use in the United States.